Regional radiotherapy in high-risk breast cancer: Is the issue solved?

M. Krause; C. Petersen; B. V. Offersen; M. Baumann

doi:10.1259/bjr.20150071

Regional radiotherapy in high-risk breast cancer: Is the issue solved?

Research output: Contribution to journal › Review article › Contributed › peer-review

Contributors

M. Krause - , Department of Radiation Oncology, OncoRay ZIC - National Center for Radiation Research in Oncology (Partners: UKD, HZDR), German Cancer Consortium (Partner: DKTK, DKFZ), University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ), Helmholtz-Zentrum Dresden-Rossendorf (Author)
C. Petersen - , University of Hamburg (Author)
B. V. Offersen - , Aarhus University (Author)
M. Baumann - , Department of Radiation Oncology, OncoRay ZIC - National Center for Radiation Research in Oncology (Partners: UKD, HZDR), German Cancer Consortium (Partner: DKTK, DKFZ), University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ), Helmholtz-Zentrum Dresden-Rossendorf (Author)

Abstract

Adjuvant radiotherapy is the treatment standard for breast cancer with lymph node metastases after breast-conserving surgery or mastectomy. The inclusion of regional lymph nodes into the treatment volumes has been a question in recent clinical trials. Their impact on treatment standards and open questions is discussed.

Details

Original language	English
Article number	20150071
Journal	British Journal of Radiology
Volume	88
Issue number	1051
Publication status	Published - 1 Jul 2015
Peer-reviewed	Yes

External IDs

PubMed	25823431

Keywords

ASJC Scopus subject areas

Radiology, Nuclear Medicine and Imaging